Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank21
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-26.55M
↓ 39% vs avg
Percentile
P21
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-19.10M
Historical baseline
PeriodValueYoY Change
2025$-26.55M+5.8%
2024$-28.20M+3.0%
2023$-29.06M-2.5%
2022$-28.36M-17.0%
2021$-24.25M-43.2%
2020$-16.93M-36.1%
2019$-12.44M-9.9%
2018$-11.32M-42.0%
2017$-7.97M-35.1%
2016$-5.90M-